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Autosomal dominant polycystic kidney disease (ADPKD)
caused by mutations in PKD1 is significantly more severe than
PKD2. Typically, ADPKD presents in adulthood but is rarely
diagnosed in utero with enlarged, echogenic kidneys. Somatic
mutations are thought crucial for cyst development, but gene
dosage is also important since animal models with
hypomorphic alleles develop cysts, but are viable as
homozygotes. We screened for mutations in PKD1 and PKD2
in two consanguineous families and found PKD1 missense
variants predicted to be pathogenic. In one family, two
siblings homozygous for R3277C developed end stage renal
disease at ages 75 and 62 years, while six heterozygotes had
few cysts. In the other family, the father and two children with
moderate to severe disease were homozygous for N3188S. In
both families homozygous disease was associated with small
cysts of relatively uniform size while marked cyst heterogeneity
is typical of ADPKD. In another family, one patient diagnosed in
childhood was found to be a compound heterozygote for the
PKD1 variants R3105W and R2765C. All three families had
evidence of developmental defects of the collecting system.
Three additional ADPKD families with in utero onset had a
truncating mutation in trans with either R3277C or R2765C.
These cases suggest the presence of incompletely penetrant
PKD1 alleles. The alleles alone may result in mild cystic disease;
two such alleles cause typical to severe disease; and, in
combination with an inactivating allele, are associated with
early onset disease. Our study indicates that the dosage of
functional PKD1 protein may be critical for cyst initiation.
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Autosomal dominant polycystic kidney disease (ADPKD) is
characterized by progressive bilateral cyst development and
expansion, often resulting in end-stage renal disease (ESRD).
The disease is genetically heterogeneous with two loci
identified: PKD1, B85% of cases (16p13.3) and PKD2,
B15% (4q21).1–3 The ADPKD phenotype displays marked
variability4 that is greatly influenced by the gene type: PKD1
has an average age at ESRD of 54.3 years compared to 74
years for PKD2.5 Significant intrafamilial variability also
highlights a role for the genetic background in the disease
presentation.6 Extreme intrafamilial variability manifests in a
small proportion of cases (B1–2%) with early onset ADPKD,
clinical symptoms before 15 years, and rarely results in in
utero cystic enlargement more typical of autosomal recessive
polycystic kidney disease.7,8 Most early onset cases have been
linked to PKD1, but recently a PKD2 family with perinatal
death in two severely affected infants was described.9–13 As
illustrated in this case, siblings of early onset cases have a
significantly enhanced risk of severe disease.8 Early onset
ADPKD can be caused by contiguous deletion of the adjacent
PKD1 and tuberous sclerosis gene (TSC2), characterized by
childhood polycystic kidney disease (PKD) with additional
clinical signs of tuberous sclerosis.14 Another genetic factor
that can modulate the disease presentation and result in
marked intrafamilial variability is mosaicism.15,16 Bilineal
inheritance of a PKD1 and a PKD2 mutant allele can also
result in a modest enhancement to the single gene
phenotypes.17
Comprehensive base-pair mutation screening of PKD1
and PKD2 has identified definite, truncating mutations in
B61% of cases; a further B4% have larger deletion/
duplication mutations.3,16 Rigorous testing of amino-acid
substitutions using a Grantham matrix score,18 plus analysis
of segregation and other detected variants, has resulted in
likely missense changes being defined in an additionalB26%
of cases. The molecular basis of disease in approximately 9%
of ADPKD remains unclear. Genotype/phenotype studies
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have suggested a modest influence of mutation position in
PKD1, but have not shown a difference in severity between
truncating and missense changes associated with either gene,
suggesting likely inactivation of these missense variants.19,20
This contrasts with autosomal recessive polycystic kidney
disease where less severe disease is associated with at least one
PKHD1 missense mutation, indicating the importance of
incompletely penetrant alleles.21
Evidence from animal models of ADPKD and analysis of
cystic epithelia indicate that renal cysts develop from loss of
functional PKD protein (polycystin) with somatic inactiva-
tion of the normal allele suggesting a two-hit mechan-
ism.22–24 However, the dosage level of functional polycystin
may also be important because mouse models expressing low
levels (o20%) of correctly spliced product develop cysts but
are viable as homozygotes.25,26 No corresponding human
hypomorphic or incompletely penetrant PKD1 or PKD2
alleles have been described. Here we describe a number of
unusual families with atypical presentations of PKD that
suggest a role for incompletely penetrant PKD1 alleles in
causing and modulating cystic disease.
RESULTS
Analysis of over 100 apparent ADPKD families, including
ones with unusually severe and mild disease and marked
intrafamilial variability, identified three that did not fit the
normal ADPKD paradigm of a single dominantly inherited
mutation.
Family M34
The proband (II2) had bilaterally enlarged kidneys and ESRD
at age 75 years whereas a brother (II3) required a renal
transplant at 62 years (Figure 1a). The appearance of the
kidneys in the two siblings was similar and atypical for
ADPKD in that multiple, relatively uniformly sized cysts were
found (Figure 1b), compared to the marked heterogeneity in
cyst size typical of this disorder. Mild dilatation of the calyces
was also seen in II2 (Figure 1b). Unusually for older ADPKD
patients, neither had liver cysts. Multiple small cortical renal
cysts were identified in the father at autopsy at 79 years. The
mother died at 83 from a stroke with PKD unknown. The
proband’s children (III1, III2, and III4) each had a small
number of renal cysts (see Figure 1a and b) without renal
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Figure 1 | Homozygous inheritance of PKD1: R3277C in a consanguineous family. (a) Pedigree of family M34 showed inheritance of PKD
through four generations, but only II2 and II3 (black shading) have renal impairment; age at ESRD is shown. Individuals with mild disease are
shaded and total cyst number detected by CT or magnetic resonance imaging at the indicated age are shown, including multiple cysts (MC)
in I1 at autopsy. Segregation of the R3277C alleles (R or C) is indicated below each patient where information is available, parenthesis
indicate inferred genotypes. (b) (II2) Unenhanced coronal MR image (top) and axial MR image (bottom) following administration of
gadolinium and (II3) unenhanced CT analysis shows bilaterally enlarged kidneys with numerous small and uniform cysts. Following the
administration of gadolinium, there is layering of the contrast (white arrows) in dilated calyces (II2). Single cysts are indicated with
arrowheads on CT (III1 and III2) or magnetic resonance imaging (III4) of mildly affected individuals. (c) Wild-type (wt), heterozygous (het),
and homozygous (hom) sequence of R3277C showing the normal and variant DNA and amino-acid sequence. (d) Multisequence alignment
of PC1 orthologues as indicated shows R3277 is invariant. PC1-like human sequences, as indicated, illustrate a high level of conservation of
R3277.
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enlargement, in their 40s. The granddaughter (IV1) had a
single cyst at 28 years, whereas another brother (II5) had five
cysts at 76 years (Figure 1a and b). Although this cyst number
was suggestive of a positive diagnosis in these individuals
with the family history of ADPKD, the severity of disease was
very different between generations.
Mutation analysis by direct sequencing of PKD1 and
PKD2 exons revealed homozygosity for 13 PKD1 intragenic
polymorphisms. Subsequently, the parents (I1 and I2) were
found to be first cousins. In addition, the novel PKD1
substitution 9829C-T, resulting in R3277C (Figure 1c), was
found homozygous in II2 and II3 and heterozygous
in other family members with renal cysts (Figure 1a). No
large deletion mutation was detected in II2 or II3 using a
multiple ligation-dependent probe amplification assay for the
PKD1 and PKD2 genes, and no PKHD1 mutations were
detected.
R3277C is at a highly conserved site in polycystin-1 (PC1),
completely conserved to fish (Grantham variation, GV¼ 0)
and is a highly nonconservative substitution (Grantham
distance, GD¼ 180) (Figure 1d).3,18 The missense change is
located in the first intracellular loop of PC1, close to
transmembrane region 2, and is highly conserved in other
PC1-like proteins (Figure 1d). To more rigorously test the
significance of this substitution, three tools to predict
pathological mutations were tested. These tools (SIFT,
PolyPhen, and AlignGVGD) were used utilizing default
conditions and/or by using an alignment of PC1 orthologues
(see Materials and Methods, Table S1 , and Supplementary
Results for details). Evaluation of R3277C showed that it was
predicted to be a strong pathogenic mutation in each case
(Table 1). Overall, this family suggested that R3277C was an
incompletely penetrant mutant allele that resulted in
occasional cyst development in heterozygotes and more
severe PKD in homozygosity.
Family P192
A second consanguineous family of Pakistani origin pre-
sented a pattern typical of dominant inheritance (Figure 2a).
The father (I1) had bilateral PKD, but as above, the finding of
multiple small cysts (4–7 mm) was not completely character-
istic of ADPKD, with clubbing of the calyces also detected. II2
had PKD diagnosed at 22 weeks gestation with large
hyperechogenic kidneys and at 14 years had slightly enlarged
kidneys with multiple (10–12 mm) cysts scattered throughout
the parenchyma. No liver cysts were detected. Glomerular
filtration rate at 15.5 years was 67 ml/min per 1.73 m2. Her
sister (II3) had bilateral renal cysts detected at 9 years and at
15 years had a normal glomerular filtration rate (86 ml/min
per 1.73 m2) with several cortical cysts, including ones of 12
and 17 mm, but no liver cysts. An earlier pregnancy that
resulted in a stillbirth (II1) was found to have bilateral PKD
but no biliary dysgenesis (typical of autosomal recessive
polycystic kidney disease) at autopsy.
Haplotype analysis with five markers flanking PKD1 (see
Materials and Methods for details) indicated homozygosity of
B450 kb around PKD1 in I1, II2, and II3 with a similar single
copy of the same haplotype in the mother (I2) and unaffected
children (II4 and II5). Sequence analysis of PKD1 and PKD2
in I1 showed homozygosity of four intragenic PKD1 single
nucleotide polymorphisms. A novel substitution in PKD1,
9563A-G; N3188S, was homozygous in the affected cases
and heterozygous in the others (Figure 2a and b). This
residue is completely conserved to fish (GV¼ 0), is a
moderately conservative change (GD¼ 46), and highly
conserved in other PC1-like proteins (Figure 2c). It lies in
the PLAT domain27 but is not at a highly conserved position
in the domain. Analysis with the prediction tools indicated
that it was most likely a pathogenic change (Table 1).
Deletion of N318828 as a mutation has been described. This
substitution is close to the junction with IVS27, but reverse
transcription–PCR analysis of this change did not reveal
abnormal splicing. A possible large deletion mutation causing
hemizygosity across the PKD1 region was excluded by
multiple ligation-dependent probe amplification analysis of
PKD1, and no PKHD1 mutations were detected.
Family M390
The proband (II5) in M390 (Figure 3a) was diagnosed by
excretory urography at 11 years with medullary sponge
kidney and bilateral renal cysts consistent with PKD,
following multiple urinary tract infections. Images at 32
years showed multiple renal cysts and three liver cysts (Figure
3b). The kidneys were not particularly enlarged (RK, 12.2 cm;
LK, 12.1 cm at 22 years). Cortical scars consistent with reflux
nephropathy were also seen, with a history of multiple
urinary tract infections during childhood. The sister (II2)
had one 2.2 cm cyst (42 years; Figure 3c), while II3 had one
kidney cyst and liver cyst (2.5 cm) but the parents were
apparently unaffected. Mutation screening of II5 revealed two
PKD1 missense variants, 9313C-T; R3105W, and 8293C-
T; R2765C (Figure 3d). R3105W is a novel, nonconservative
change (GD¼ 101) at a well-conserved site in orthologues
(GV¼ 26) and homologues (Figure 3e). R2765C is a
nonconservative change (GD¼ 180) at a conserved site of
basic residues (GV¼ 29), but is not part of a conserved
domain (Figure 3f). Formal analysis of these variants
predicted that both are likely pathogenic changes (Table 1).
Various other members of the family had one or other of the
variants but not both (Figure 3a), including the sisters with
Table 1 | Scoring of PC1 variants for likely pathogenicity
SIFTa SIFTb PolyPhena AlignGVGDb Consensus
Variant MG VS MG VS MG VS MG VS MG
R2765C C 0.01 C 0.01 B 2.17 C C35 B/C
R3105W B 0 B 0 B 2.60 C C35 B
N3188S C 0.03 B 0 C 1.84 C C45 C
R3277C B 0 B 0 B 2.65 B C65 B
B, highly likely; C, likely; MG, mutation group; PC1; polycystin-1; VS, variant score.
aDefault alignment.
bPC1 orthologue alignment.
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single renal cysts. The pattern of inheritance suggested that
both incompletely penetrant variants are required for
polycystic kidney disease development and that a single
variant can be associated with rare cyst development.
In utero onset ADPKD
We reasoned that the identified incompletely penetrant PKD1
alleles in trans with an inactivating allele may cause early
onset ADPKD; hence, we screened families with an in utero
presentation of PKD and a family history of ADPKD. In
P438; III1 (Figure 4a), PKD was diagnosed in utero with
bilateral, substantially enlarged hyperechogenic kidneys
(RK¼ 9 cm; LK¼ 10 cm) at 7 days, and hypertension
diagnosed at 5 months. The kidneys had no corticomedullary
differentiation and multiple small cysts, with an SC¼ 1.7 mg/
100 ml at 17 years. The father was diagnosed with ADPKD at
15 years and had an SC¼ 1.5 mg/100 ml at 44 years. The
grandmother had ESRD at 43 years. Screening the ADPKD
genes showed PKD1: Q2158X as the likely disease-causing
mutation, but that the in utero case (III1) also had the
R3277C variant, presumably inherited from the apparently
unaffected mother.
In P117, one (III2) of a pair of dizygotic twins was
diagnosed in utero at 31 weeks with enlarged bilaterally cystic
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Figure 2 | Homozygous inheritance of PKD1: N3188S in a consanguineous Pakistani family. (a) Pedigree showing renal phenotype;
multiple cysts (MC), in utero (IU) PKD, or negative ultrasound (ve U/S) and the genotype of N3188S (N or S). (b) Sequence of N3188S
showing the wild-type (wt), heterozygous (het), and homozygous (hom) DNA and amino-acid sequence. The position of IVS27 is also
indicated. (c) Sequence alignment of PC1 orthologues and human PC1-like proteins as indicated. N3188 is completely conserved in the
orthologues and well conserved in homologues, but is serine in PC1L1.
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kidneys that were at the 95th percentile (8 cm) at 10
months.12 III2 was hypertensive since age 2 years and had
multiple bilateral cysts and a glomerular filtration rate of
89 ml/min per 1.73 m2 at 15 years. Her twin brother III1 had
more typical ADPKD with two cysts in the left kidney and
one in the right at 10 years. Their father had multiple renal
cysts, but normal renal function at 28 years (Figure 4b). In
P118, III1 died perinatally of pulmonary hypoplasia with
massively enlarged cystic kidneys.19 The mother II2 had
multiple cysts and enlarged kidneys at 35 years, typical of
ADPKD, and five cysts were found (up to 5 cm in diameter)
in I1. In both families the nonconservative variant R2765C
was found inherited in trans with a truncating mutation
(P117; Y3819X: P118; 7915dup20)12,29 in the severely affected
cases (Figure 4b and c). Cases with just the R2765C variant
did not have renal cysts by ultrasound examination. Unlike
the other variants described here that have only been seen in
these families, R2765C is a more common variant found on
B1% of normal alleles and described in three studies.30 In
two other families analyzed with typical ADPKD, R2765C
segregated in cis with the likely pathogenic mutation, whereas
segregation data were not available in three other families
with that variant.
DISCUSSION
We have analyzed three families with ADPKD-like disease
that are not explained by dominant inheritance of a single
mutation to PKD1 or PKD2. Several pieces of data indicate a
novel mechanism, including the pattern of inheritance and
haplotypes, unusual distribution of cysts, sequence analysis of
PKD1 and PKD2 and scoring of variants, and exclusion of
other causes of disease. Consistent with the ADPKD-like
phenotype, we provide strong data that atypical PKD1 alleles
underlie the disease etiology in these families.
The inheritance pattern in M34 is consistent with
autosomal dominance but it exhibits extreme differences in
severity between generations. Although intrafamilial varia-
bility is seen in ADPKD,31 it does not usually range from
ESRD in 60s to the minimal cyst development in the 40s, as
seen here. The homozygosity of a highly conserved PKD1
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Figure 3 | Family M390-inherited PKD1 variants: R2765C and R3105W. (a) Pedigree of M390 showing the proband II5, who has multiple
cysts (MC) in the kidney, and mildly affected individuals (II2 and II3) with single cysts; negative imaging data and age are illustrated. The
R2765C (R or C) and R3105W (R or W) genotypes are shown below. Only II5 is a compound heterozygote. (b) CT images of II5 kidney (top
and middle) showing multiple renal cysts and (bottom) a single liver cyst (arrowheads). (c) CT of II2 showing a single large cyst. (d) Sequence
data illustrating the two variants showing the nucleotide and amino-acid changes. (e) Sequence alignment of PC1 orthologues and human
PC1-like homologous proteins. R3105 is highly conserved as a basic residue in all homologues. (f) Multisequence alignment of PC1
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mutation in the cases with ESRD, plus heterozygosity in
those with a few cysts, suggested the involvement of an
incompletely penetrant allele. In P192, the inheritance
pattern is apparently dominant, but haplotype and sequence
data again showed a PKD1 homozygous mutation associated
with moderate to severe cystic disease. In the final family,
M390, inheritance appears recessive and only the compound
heterozygote with two highly conserved PKD1 variants has
significant cystic disease.
PKD1 is highly polymorphic with B10 neutral variants
found per patient from exonic sequencing.3 However, the
majority are known variants, whereas most novel neutral
changes are at poorly conserved sites or are conservative
substitutions (Table S1). The four variants highlighted in this
study bear all the characteristics of pathogenic missense
changes. This is reflected in both the Grantham matrix score
and the more formal analysis of likely pathogenicity that rates
them as ‘highly likely’ (Mutation Group B) or ‘likely’
(Mutation Group C)3 mutations. However, it is clear from
the heterozygous phenotypes that none are fully penetrant
mutations as at the most extreme they are only associated
with a handful of renal cysts by middle age. We propose that
these partially penetrant alleles, associated with a protein
with some residual function (similar to some PKHD1
missense changes) are functionally analogous to described
murine Pkd1 hypomorphic alleles.25,26
To prove the significance of these variants, a functional
test for PC1 is required, but unfortunately no such assay yet
exists. In parts of the protein (the REJ and GPS regions), the
significance of missense changes has been assessed by their
ability to prevent cleavage at the GPS site.32 However, the
variants described here in the transmembrane region are
unlikely to influence cleavage. Furthermore, as we propose
that these are incompletely penetrant alleles, obtaining
clear results from any functional assay may be difficult.
Mimicking these changes in a mouse knock-in model (a
time-consuming process) may be the only clear way to prove
their significance.
Recently, a homozygous PKD2 variant, F482C, that alters
polycystin-2 channel activity, was suggested to modulate
disease due to a PKD1 splicing mutation.33 Syndromic forms
of PKD also exhibit genetic complexity, including oligogenic
inheritance and phenotypic modulation by hypomorphic
mutations.34–36 We propose here that specific PKD1 variants
can be important in modulating cyst development. In the
heterozygous state, they may be a significant cause of simple
renal cysts, a small number of which often develop in normal
individuals as they age.37 In unusual cases (sometimes
associated with consanguinity), they can cause typical to
severe PKD as a homozygote or a compound heterozygote.
The pattern of inheritance may appear recessive or with large
intergenerational differences in severity. The disease gene
may be impossible to map in such cases, which could
underlie some unlinked ADPKD families, akin to the
described family with bilineal disease.17,38 These incompletely
penetrant alleles could also act as a disease modifier that in
trans with an inactivating mutation can result in early onset
disease, as a result of only a low level of available functional
protein. These alleles would explain the recurrence risk
within families, and the R2765C allele found in B1% of
alleles could be a major modulator of disease. This
mechanism is unlikely to explain all early onset cases
(including ones with more complex family relationships)7,39
and stochastic factors and genetic background also likely
impact the severity of disease. Nevertheless, we propose that
these incompletely penetrant alleles are important.
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It is intriguing that the three homozygous/compound
heterozygous cases had likely developmental defects of the
collecting system, an abnormality rarely seen in ADPKD. The
uniform pattern of multiple small cysts in the homozygous
cases, as also often seen in childhood cases40 (including here),
suggests that the mechanism of cystogenesis may be different
than in typical, dominantly inherited PKD1. In that case,
somatic events are thought to be important for cyst
development;22 the wide variety in cyst size may reflect
somatic changes occurring at different times, although
differences in growth rates between cysts may also be
important.41 The uniformity of cyst size seems to indicate
that cyst initiation may have occurred at a similar time
without a secondary genetic event, perhaps at a time during
development when a critical level of functional PC1 is most
important. Recently, conditional knockout models of Pkd1
have identified a critical period up to shortly after birth (P13d)
when inactivation of both alleles results in severe cystic disease,
whereas inactivation after P14d causes much milder dis-
ease.42,43 The unusual cases described here raise the question of
how much a threshold level of PC1 during development may
also be critical to cystogenesis in typical ADPKD patients.
MATERIALS AND METHODS
Sample collection
The study was approved by the relevant institutional review board
or ethics committee and participants gave informed consent.
Families were collected in the United States (M34 and M390), UK
(P192, P117, and P118), and France (P438). Blood samples and
clinical/imaging data were collected on as many cases as possible,
and new computed tomography (CT) or magnetic resonance
imaging analysis was performed when necessary. Pedigrees P117
and P118 were published previously and further clinical details were
described.12,44
Haplotype analysis
Family members were screened with microsatellite markers within
and flanking PKD1: KG8, SM6, 16AC2.5, CW2, and SM745 using
methods previously described.46
Mutation screening and classification of variants
DNA was isolated from whole blood using the Puregene DNA
Purification System. Mutations were screened in the proband in each
family by direct sequencing of exonic and flanking introgenic regions.3
Segregation was tested by sequence analysis of the relevant genomic
fragment in family members. All variants are numbered as previously
indicated.3 The significance of missense variants (GD) was assessed
using the Grantham matrix score.18 The GV was assessed as the largest
Grantham matrix score between orthologues in a multisequence
alignment of human, mouse, rat, chicken, Xenopus, and Takifugu
sequence as previously defined.3 Homologous proteins to PC1 were:
PC1L1, PC1L2, PC1L3, PKDREJ, and the sea urchin (Strongylocen-
trotus purpuratus) proteins REJ3, 4, 5, 6, and 7.47 Evidence for previous
descriptions of the variants was obtained from the ADPKD Mutation
Database (http://pkdb.mayo.edu).
Formal analysis of the likelihood that substitutions were patho-
genic was performed using three programs: SIFT (http://blocks.
fhcrc.org/sift/SIFT.html), PolyPhen (http://genetics.bwh.harvard.
edu/pph/), and Align GVGD (http://agvgd.iarc.fr/agvgd_input.php)
that assess the changes in light of conservation in a multisequence
alignment. Orthologous and homologous sequences detected by the
program were used for SIFT and PolyPhen, whereas a multisequence
alignment of PC1 orthologues as above, plus dog, opossum, and
Tetraodon nigroviridis was used for AlignGVGD and SIFT. Scores
from these programs were interpreted similar to the four categories
of changes used to define ADPKD mutations:3 Mutation Group
(MG)¼B (highly likely); MG¼C (likely); Indeterminate (I); and
Neutral (N). Specifically for SIFT: variant score 0.0 (B), 0.01–0.04
(C), 0.05–0.09 (I), 40.01 (N); PolyPhen: 42.0 (B), 1.99–1.5 (C),
1.49–1.4 (I), o1.39 (N); AlignGVGD: C55–C65 (B), C35–45 (C),
C15–25 (I), C00 (N). To assess the programs, 21 previously scored
variants were assayed (See Supplementary Results and Table S1).
Multiple ligation-dependent probe amplification
Large deletions or duplications of PKD1 or PKD2 were screened
using a multiple ligation-dependent probe amplification assay as
previously described.16
PKHD1 mutation analysis
Exonic and flanking intronic regions of PKHD1 were screened by
direct sequencing for mutations using a clinical test (Molecular
Genetics, Mayo Clinic, Rochester, MN, USA).
Reverse transcription–PCR
RNA isolation and cDNA generation was performed as previously
described.3 To analyze 9829C-T (R3277C) in exon 28 and
9563A-G (N3188S) in exon 27, PKD1-specific LR-RT-PCR primers
in exons 25 and 34 were used.48 The exon 25–29 region was
subsequently amplified and analyzed by agarose gel electrophoresis
and sequencing. No evidence of alternative splicing specific to the
mutation was detected.
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